Streptococcus pneumoniae: Proteomics of surface proteins for vaccine development

Clinical Microbiology and Infection

Volumn 14, Issue 1, 2008, Pages 74-81

  Morsczeck, C ^a   Prokohova, T ^a   Sigh, J ^a   Pfeiffer, M ^a   Bille Nielsen, M ^a   Petersen, J ^a   Boysen, A ^a   Kofoed, T ^a   Frimodt Moller N ^b   Nyborg Nielsen, P ^a   Schrotz King, P ^a  

^a ACE BioSciences AS   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

Author keywords

Animal model; Cell wall proteins; Immunogenicity; Proteomics; Streptococcus pneumoniae; Vaccine candidates

Indexed keywords

BACTERIAL ANTIGEN; ENDOPEPTIDASE CLP; LIGASE; LIPOATE PROTEIN LIGASE; MEMBRANE PROTEIN; PROTEIN ACE029; PROTEIN ACE060; PROTEIN ACE097; PROTEIN ACE607; PROTEIN ACE653; STREPTOCOCCUS VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIUM ISOLATE; COLONY FORMING UNIT; COMPUTER MODEL; CONTROLLED STUDY; DRUG SCREENING; DRUG SYNTHESIS; ESCHERICHIA COLI; IN VITRO STUDY; IN VIVO STUDY; MORTALITY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PURIFICATION; PROTEOMICS; SEROTYPE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

ANIMALIA; ESCHERICHIA COLI; STREPTOCOCCUS PNEUMONIAE;

EID: 36849086796     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2007.01878.x     Document Type: Article

References (27)

1. Fedson DS, Scott JA. The burden of pneumococcal disease among adults in developed and developing countries: What is and is not known. Vaccine 1999; 17 (suppl 1): S11-S18.
2. Mulholland K. Strategies for the control of pneumococcal diseases. Vaccine 1999; 17 (suppl 1): S79-S84.
3. Shinefield HR, Black S, Ray P et al. Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers. Pediatr Infect Dis J 1999; 18: 757-763.
4. Robbins JB, Austrian R, Lee CJ et al. Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. J Infect Dis 1983; 148: 1136-1159.
5. Gray BM, Dillon HC. Clinical and epidemiologic studies of pneumococcal infection in children. Pediatr Infect Dis 1986; 5: 201-207.
6. Briles DE, Ades E, Paton JC et al. Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae. Infect Immun 2000; 68: 796-800.
7. Wu HY, Nahm MH, Guo Y et al. Intranasal immunization of mice with PspA (pneumococcal surface proteinA) can prevent intranasal carriage, pulmonary infection, and sepsis with Streptococcus pneumoniae. J Infect Dis 1997; 17: 839-846.
8. Gor DO, Ding X, Briles DE et al. Relationship between surface accessibility for PpmA, PsaA, and PspA and antibody-mediated immunity to systemic infection by Streptococcus pneumoniae. Infect Immun 2005; 73: 1304-1312.
9. Swiatlo E, King J, Nabors GS et al. Pneumococcal surface proteinA is expressed invivo, and antibodies to PspA are effective for therapy in a murine model of pneumococcal sepsis. Infect Immun 2003; 71: 7149-7153.
10. Brown JS, Ogunniyi AD, Woodrow MC et al. Immunization with components of two iron uptake ABC transporters protects mice against systemic Streptococcus pneumoniae infection. Infect Immun 2001; 69: 6702-6706.
11. Ogunniyi AD, Woodrow MC, Poolman JT et al. Protection against Streptococcus pneumoniae elicited by immunization with pneumolysin and CbpA. Infect Immun 2001; 69: 5997-6003.
12. Wizemann TM, Heinrichs JH, Adamou JE et al. Use of a whole genome approach to identify vaccine molecules affording protection against Streptococcus pneumoniae infection. Infect Immun 2001; 69: 1593-1598.
13. Rodriguez-Ortega MJ, Norais N, Bensi G et al. Characterization and identification of vaccine candidate proteins through analysis of the groupA Streptococcus surface proteome. Nat Biotechnol 2006; 24: 191-197.
14. Mortz E, Krogh TN, Vorum H et al. Improved silver staining protocols for high sensitivity protein identification using matrix-assisted laser desorption/ionization-time of flight analysis. Proteomics 2001; 1: 1359-1363.
15. Frimodt-Moller N, Thomsen VF. The pneumococcus and the mouse protection test: Inoculum, dosage and timing. Acta Pathol Microbiol Immunol Scand (B) 1986; 94: 33-37.
16. Fountoulakis M, Gasser R. Proteomic analysis of the cell envelope fraction of Escherichia coli. Amino Acids 2003; 24: 19-41.
17. Kyte J, Doolittle RF. A simple method for displaying the hydropathic character of a protein. J Mol Biol 1982; 157: 105-132.
18. Klein P, Kanehisa M, DeLisi C. The detection and classification of membrane-spanning proteins. Biochim Biophys Acta 1985; 815: 468-476.
19. Ling E, Feldman G, Portnoi M et al. Glycolytic enzymes associated with the cell surface of Streptococcus pneumoniae are antigenic in humans and elicit protective immune responses in the mouse. Clin Exp Immunol 2004; 138: 290-298.
20. Hughes MJ, Moore JC, Lane JD et al. Identification of major outer surface proteins of Streptococcus agalactiae. Infect Immun 2002; 70: 1254-1259.
21. Cole JN, Ramirez RD, Currie BJ et al. Surface analyses and immune reactivities of major cell wall-associated proteins of group A Streptococcus. Infect Immun 2005; 73: 3137-3146.
22. Siegel JL, Hurst SF, Liberman ES et al. Mutanolysin-induced spheroplasts of Streptococcus mutants are true protoplasts. Infect Immun 1981; 31: 808-815.
23. Aaberge IS, Eng J, Lermark G et al. Virulence of Streptococcus pneumoniae in mice: A standardized method for preparation and frozen storage of the experimental bacterial inoculum. Microb Pathog 1995; 18: 141-152.
24. Areas AP, Oliveira ML, Miyaji EN et al. Intradermal immunization of mice with cholera toxin B-pneumococcal surface protein A fusion protein is protective against intraperitoneal challenge with Streptococcus pneumoniae. Infect Immun 2005; 73: 3810-3813.
25. Kwon HY, Ogunniyi AD, Choi MH et al. The ClpP protease of Streptococcus pneumoniae modulates virulence gene expression and protects against fatal pneumococcal challenge. Infect Immun 2004; 72: 5646-5653.
26. Cao J, Chen D, Xu W et al. Enhanced protection against pneumococcal infection elicited by immunization with the combination of PspA, PspC, and ClpP. Vaccine 2007; 25: 4996-5005.
27. O'Riordan M, Moors MA, Portnoy DA. Listeria intracellular growth and virulence require host-derived lipoic acid. Science 2003; 302: 462-464.